Skip to content

Effects Of Breath And Stacking-Spirometry Incentive in Patients With Parkinson's Disease

EFFECTS OF BREATH AND STACKING-SPIROMETRY INCENTIVE PACKAGES IN THE RIB CAGE IN PATIENTS WITH PARKINSON'S DISEASE

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01932684
Enrollment
15
Registered
2013-08-30
Start date
2012-06-30
Completion date
2012-12-31
Last updated
2013-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease.

Brief summary

Objective: To evaluate the effects of technical-Breath Stacking (BS) and incentive spirometry (IS) on the volume of the chest immediately after and within thirty minutes after the techniques in patients with Parkinson's disease (PD). Methods: This is a study of cross-over. The study investigated 14 patients with mild to moderate PD. The subjects performed the technique Breath-Stacking, incentive spirometry volume and participated in a phase control according to randomization. The volunteers were evaluated by opto-electronic plethysmography in four stages: before, immediately after fifteen and thirty minutes after the completion of the techniques. The investigators used a repeated measures ANOVA with post-hoc Tukey test for parametric variables, and the Friedman test with post-hoc Dunns for nonparametric variables. The level of significance was set at 5%, p \<0.05.

Interventions

We used a silicone face mask, connected to a unidirectional valve which allowed only inspiration and is connected to a spirometer showed that the volume inspired by the individual. The face mask was attached to the appraised performed successive breaths until the researcher realized the lack of volume of air being inhaled and this time it was allowed to expire (Baker et al., 1990; Feitosa et al., 2012).

OTHERIncentive spirometry

We used an incentive spirometer volume (5000 Voldyne ® Sherwood Medical, USA). Subjects performed slow, deep inhalations from functional residual capacity to total lung capacity, seeking to sustain the inspiration for at least three seconds (Restrepo et al., 2011).

DEVICE5000 Voldyne ® Sherwood Medical, USA
DEVICESilicone face mask

Sponsors

Universidade Federal de Pernambuco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Regular pharmacological treatment with levodopa and / or medications antiparkinsonian.

Exclusion criteria

* Patients who had previous lung disease; * Altered mental status indicated by the MMSE (Mini Mental State Examination; * A change in medication during the study; * Demonstrated inability to perform satisfactorily any of the collection procedures of the study.

Design outcomes

Primary

MeasureTime frame
The variation of the total volume and compartmental between technique Breath-Stacking in patients with Parkinson's disease25 days
The variation of the total volume and compartmental in the technique incentive spirometry in patients with Parkinson's disease25 days

Secondary

MeasureTime frame
The duration of the effects of technical-Breath Stacking and incentive spirometry in patients with Parkinson's disease25 days

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026